We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Filiopoulos, V, Hadjiyannakos, D, Vlassopoulos, D. Antimicrobial lock solutions in the prevention of catheter-related bloodstream infections in patients receiving hemodialysis. Infect Control Hosp Epidemiol2012;34:329–330 (in this issue).Google Scholar
2
2.Boyce, JM. Prevention of central line-associated bloodstream infection in hemodialysis patients. Infect Control Hosp Epidemiol2012;33:936–944.Google Scholar
3
3.Filiopoulos, V, Hadjiyannakos, D, Koutis, I, et, al. Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trialAm J Nephrol2011;33:260–268.Google Scholar
4
4.Moran, J, Sun, S, Khababa, I, Pedan, A, Doss, S, Schiller, B. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patientsAm J Kidney Dis2012;59(1):102–107.Google Scholar
5
5.Maki, DG, Ash, SR, Winger, RK, Lavin, P; AZEPTIC Trial Investigators. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Crit Care Med2011;39:613–620.Google Scholar
6
6.Betjes, MGH. Prevention and management of catheter-related infection in patients on hemodialysisNat Rev Nephrol2011;7:257–265.Google Scholar
7
7.Lok, CE, Mokrzycki, MH. Prevention and management of catheter-related infection in hemodialysis patientsKidney Int2011; 79:587–598.Google Scholar